Oppenheimer & Co’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Oppenheimer & Co’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,388	Closed	-$406K	–	1584
2014 Q4	$406K	Sell	15,388 -5,661	-27%	-$166K	0.01%	905
2014 Q3	$635K	Buy	21,049 +6	+0%	+$186	0.02%	763
2014 Q2	$663K	Buy	21,043 +600	+3%	+$19K	0.02%	763
2014 Q1	$662K	Buy	20,443 +263	+1%	+$9.21K	0.02%	738
2013 Q4	$734K	Buy	20,180 +4,742	+31%	+$184K	0.02%	680
2013 Q3	$601K	Sell	15,438 -1,254	-8%	-$50.5K	0.02%	709
2013 Q2	$625K	Buy	+16,692	New	+$659K	0.02%	648

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Oppenheimer & Co's MR Position: Q1 2015 in Review

Oppenheimer & Co sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2015, closing a stake of 15,388 shares — an estimated $406K sold.

Oppenheimer & Co first reported a position in MR in Q2 2013 and held it in 7 quarters. The position peaked at $734K in Q4 2013. 124 funds tracked by Wall St. Rank hold MR as of Q1 2015.

Oppenheimer & Co reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2015 after selling out during the quarter.
Oppenheimer & Co sold 15,388 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2015, an estimated $406K.
Oppenheimer & Co first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 7 quarters.
Oppenheimer & Co's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $734K in Q4 2013.
124 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2015.

Based on Oppenheimer & Co's 13F filing for Q1 2015, filed 8 May 2015.